Department of Medical Pathology, University of California, Davis Medical Center, Sacramento, 95817, USA.
Clin Hemorheol Microcirc. 2011;47(2):131-41. doi: 10.3233/CH-2010-1374.
We hypothesized that T2DM vasculopathy can be revealed and quantified in the bulbar conjunctiva prior to its pathologic presentation in the retina. Using computer-assisted intravital microscopy (CAIM), an objective, non-invasive approach can provide a viable complement to retinal fundus photography to possibly screen patients for early signs of real-time, in vivo T2DM vasculopathy. Fundus photography was utilized to determine the retinopathy level (RL) in T2DM patients with non-proliferative diabetic retinopathy (NPDR) and control subjects. CAIM was used to quantify microangiopathy in the bulbar conjunctiva in the same patients, and reported on a severity index (SI). The average RL for the T2DM patients in this study is 19.68 ± 9.91, which differs from control subjects (RL = 10 ± 0.0; p < 0.05). A significant difference in vasculopathy was observed in the conjunctival microcirculation in the same patients (SI = 5.81 ± 1.30) when compared with control subjects (SI = 1.33 ± 1.58; p < 0.05). The results provide evidence that significant vasculopathy had developed in the microcirculation in the bulbar conjunctiva, though diabetic retinopathy had not developed significantly in the same patients - indicative of the presence of a time window for early intervention of T2DM before non-proliferative retinopathy develops, and the real-time availability of the conjunctival microvasculature as an in vivo platform to monitor disease progression.
我们假设 T2DM 血管病变可在视网膜出现病理表现之前,在球结膜中被揭示和量化。使用计算机辅助活体显微镜(CAIM),一种客观、非侵入性的方法可以为视网膜眼底摄影提供可行的补充,以可能筛选出有实时、活体 T2DM 血管病变早期迹象的患者。眼底摄影用于确定患有非增生性糖尿病视网膜病变(NPDR)的 T2DM 患者和对照受试者的视网膜病变水平(RL)。CAIM 用于量化同一患者球结膜中的微血管病变,并报告严重指数(SI)。本研究中 T2DM 患者的平均 RL 为 19.68±9.91,与对照组(RL=10±0.0;p<0.05)不同。在同一患者中,观察到结膜微循环中的血管病变有显著差异(SI=5.81±1.30),与对照组(SI=1.33±1.58;p<0.05)相比。结果表明,尽管同一患者的糖尿病视网膜病变尚未明显发展,但球结膜微循环中的微血管病变已显著发展——这表明在非增生性视网膜病变发生之前,T2DM 有早期干预的时间窗口,并且结膜微血管作为实时监测疾病进展的活体平台。